|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 4 of 38 found articles
| Title: |
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF V600E or BRAF V600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study |
| Author: |
Robert, Caroline Kicinski, Michal Dutriaux, Caroline Routier, Émilie Govaerts, Anne-Sophie Bührer, Emanuel Neidhardt, Eve-Marie Durando, Xavier Baroudjian, Barouyr Saiag, Philippe Gaudy-Marqueste, Caroline Ascierto, Paolo A Arance, Ana Russillo, Michelangelo Perrot, Jean-Luc Mortier, Laurent Aubin, Francois Dalle, Stéphane Grange, Florent Muñoz-Couselo, Eva Mary-Prey, Sorilla Amini-Adle, Mona Mansard, Sandrine Lebbe, Céleste Funck-Brentano, Elisa Monestier, Sandrine Eggermont, Alexander M M Oppong, Felix Wijnen, Leen Schilling, Bastian MandalÁ, Mario Lorigan, Paul van Akkooi, Alexander C J |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 26 () nr. 6 pages 781-794 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 4 of 38 found articles
| << previous | next >> |